Early Relapse post Autologous Transplant is Associated With Very Poor Survival and Identifies an Ultra High Risk Group of Myeloma Patients

Abstract Patients relapsing early after autologous stem cell transplantation (ASCT) are a particular therapeutic challenge. Among 297 consecutive patients receiving first-line ASCT, 43(14.5%) relapsed within 5 years (p 6 years. The survival after an early relapse has not improved significantly over time. In multivariate analysis, early relapse (HR:14, p